Search Keyword:


Search option:


IID00383
UniprotQ13501
ProteinSequestosome-1
GeneSQSTM1
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
440
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 3-102 Hetero dimer : P09217
 Evidence X-RAY 4mjs R Reference
       Region 4mjs R 3-12 order
       Region 4mjs R 13-14 disorder
       Region 4mjs R 15-26 order
       Region 4mjs R 27-40 disorder
       Region 4mjs R 41-102 order
 Evidence X-RAY 4mjs P Reference
       Region 4mjs P 3-3 disorder
       Region 4mjs P 4-11 order
       Region 4mjs P 12-14 disorder
       Region 4mjs P 15-26 order
       Region 4mjs P 27-41 disorder
       Region 4mjs P 42-102 order
 Evidence X-RAY 4mjs N Reference
       Region 4mjs N 3-11 order
       Region 4mjs N 12-14 disorder
       Region 4mjs N 15-26 order
       Region 4mjs N 27-40 disorder
       Region 4mjs N 41-102 order
 Evidence X-RAY 4mjs L Reference
       Region 4mjs L 3-26 order
       Region 4mjs L 27-40 disorder
       Region 4mjs L 41-102 order
 Evidence X-RAY 4mjs J Reference
       Region 4mjs J 3-27 order
       Region 4mjs J 28-40 disorder
       Region 4mjs J 41-102 order
 Evidence X-RAY 4mjs H Reference
       Region 4mjs H 3-12 order
       Region 4mjs H 13-14 disorder
       Region 4mjs H 15-26 order
       Region 4mjs H 27-40 disorder
       Region 4mjs H 41-102 order
 Evidence X-RAY 4mjs F Reference
       Region 4mjs F 3-11 order
       Region 4mjs F 12-14 disorder
       Region 4mjs F 15-26 order
       Region 4mjs F 27-40 disorder
       Region 4mjs F 41-102 order
 Evidence X-RAY 4mjs D Reference
       Region 4mjs D 3-11 order
       Region 4mjs D 12-14 disorder
       Region 4mjs D 15-26 order
       Region 4mjs D 27-40 disorder
       Region 4mjs D 41-102 order
 Evidence X-RAY 4mjs X Reference
       Region 4mjs X 3-27 order
       Region 4mjs X 28-40 disorder
       Region 4mjs X 41-102 order
 Evidence X-RAY 4mjs V Reference
       Region 4mjs V 3-3 disorder
       Region 4mjs V 4-11 order
       Region 4mjs V 12-14 disorder
       Region 4mjs V 15-25 order
       Region 4mjs V 26-40 disorder
       Region 4mjs V 41-101 order
       Region 4mjs V 102-102 disorder
 Evidence X-RAY 4mjs T Reference
       Region 4mjs T 3-11 order
       Region 4mjs T 12-14 disorder
       Region 4mjs T 15-26 order
       Region 4mjs T 27-40 disorder
       Region 4mjs T 41-102 order
 Evidence X-RAY 4mjs B Reference
       Region 4mjs B 3-3 disorder
       Region 4mjs B 4-11 order
       Region 4mjs B 12-14 disorder
       Region 4mjs B 15-26 order
       Region 4mjs B 27-40 disorder
       Region 4mjs B 41-102 order
Seq 387-436 Homo dimer :
 Evidence NMR 2knv B Reference
       Region 2knv B 387-436 order
 Evidence NMR 2knv A Reference
       Region 2knv A 387-436 order
Seq 387-436 Monomer :
 Evidence NMR 1q02 A Reference
       Region 1q02 A 387-436 order
       Region 1q02 A 387-390 high_rmsd
       Region 1q02 A 435-436 high_rmsd
 Evidence NMR 2k0b X Reference
       Region 2k0b X 387-436 order
 Evidence NMR 2jy8 A Reference
       Region 2jy8 A 387-436 order
       Region 2jy8 A 435-436 high_rmsd
 Evidence NMR 2jy7 A Reference
       Region 2jy7 A 387-436 order
       Region 2jy7 A 436-436 high_rmsd
Seqphosphorylation
    24-24 Phosphoserine
    148-148 Phosphotyrosine
    170-170 Phosphoserine
    176-176 Phosphoserine
    207-207 Phosphoserine
    233-233 Phosphoserine
    249-249 Phosphoserine
    266-266 Phosphoserine
    269-269 Phosphothreonine
    272-272 Phosphoserine
    282-282 Phosphoserine
    306-306 Phosphoserine
    328-328 Phosphoserine
    332-332 Phosphoserine
    349-349 Phosphoserine; by ULK1
    355-355 Phosphoserine
    361-361 Phosphoserine
    365-365 Phosphoserine
    366-366 Phosphoserine
    403-403 Phosphoserine; by CK2
    407-407 Phosphoserine; by ULK1
Seqacetylation
    2-2 N-acetylalanine
    420-420 N6-acetyllysine; alternate
    435-435 N6-acetyllysine; alternate
    2-2 N-acetylalanine
 
Prediction
NeProc
Disorder 179-185,211-382,434-440
Order 1-28,36-178,186-210,383-433
ProS 179-185,211-227,232-260,293-299,330-346
AlphaFold
Disorder 1-2,28-40,104-120,172-230,268-390,433-440
Order 3-27,41-103,121-171,231-267,391-432
Pfam Hmmer
PF00564 20-102 4.8e-12
PF00569 122-166 9.4e-11
SEG 29-43 ,208-220 ,269-296
Function
Function in SwissProt
Autophagy receptor required for selective macroautophagy (aggrephagy). Functions as a bridge between polyubiquitinated cargo and autophagosomes. Interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family (PubMed:16286508, PubMed:20168092, PubMed:24128730, PubMed:28404643, PubMed:22622177). Along with WDFY3, involved in the formation and autophagic degradation of cytoplasmic ubiquitin-containing inclusions (p62 bodies, ALIS/aggresome-like induced structures). Along with WDFY3, required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed:24128730, PubMed:20168092). May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1. May play a role in titin/TTN downstream signaling in muscle cells. May regulate signaling cascades through ubiquitination. Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). May be involved in cell differentiation, apoptosis, immune response and regulation of K(+) channels. Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed:20452972, PubMed:28380357).